BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA
124 results:

  • 1. Association between 3D membranous urethral parameters and urinary continence recovery after RARP.
    Wang M; Deng R; Wang L; Li M; Zeng T; Na Y; Gu D
    Eur J Med Res; 2024 Mar; 29(1):165. PubMed ID: 38475943
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
    J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
    Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
    Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Change in total lesion PSMA (TLP) during [
    Burgard C; Hein C; Blickle A; Bartholomä M; Maus S; Petto S; Schaefer-Schuler A; Ezziddin S; Rosar F
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):885-895. PubMed ID: 37889298
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Influence of Humoral Response Against GnRH, Generated by Immunization with a Therapeutic Vaccine Candidate on the Evolution of Patients with Castration-Sensitive prostate Adenocarcinoma.
    Campal-Espinosa AC; Junco-Barranco JA; Fuentes-Aguilar F; Calzada-Aguilera L; Rivacoba-Betancourt A; Rodríguez-Bueno RH; Bover-Campal AC; Bover-Fuentes EE; González L; de Quesada L; Alvarez A; Garay-Pérez HE
    Technol Cancer Res Treat; 2023; 22():15330338231207318. PubMed ID: 37828833
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Variations in predictors for urinary continence recovery at different time periods following robot-assisted radical prostatectomy.
    Nitta M; Tazawa M; Takahashi K; Naruse J; Oda K; Kano T; Uchida T; Umemoto T; Ogawa T; Kawamura Y; Hasegawa M; Shoji S; Miyajima A
    Asian J Endosc Surg; 2024 Jan; 17(1):e13243. PubMed ID: 37740401
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Elderly Patients' Outcomes After Robot-Assisted Radical prostatectomy: A Single Center Experience.
    Islamoglu E; Aksaray EE; Tas S; Ari O; Boga MS; Ates M; Savas M
    J Laparoendosc Adv Surg Tech A; 2023 Nov; 33(11):1097-1101. PubMed ID: 37646643
    [No Abstract]    [Full Text] [Related]  

  • 8. A case of paraneoplastic iga nephropathy with glomerular capillary iga and galactose-deficient iga1 deposition.
    Isogai E; Iwazu Y; Akimoto T; Kuro-O M; Niki T; Nagata D
    CEN Case Rep; 2024 Apr; 13(2):104-109. PubMed ID: 37434086
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Plant-derived PAP proteins fused to immunoglobulin A and M Fc domains induce anti-prostate cancer immune response in mice.
    Kang YJ; Kim DS; Kim S; Seo YJ; Ko K
    BMB Rep; 2023 Jul; 56(7):392-397. PubMed ID: 37037672
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
    Su CH; Chen WM; Chen MC; Shia BC; Wu SY
    Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Nationwide Study of Differences in Surgical Treatment Rates and Oncological Outcomes for prostate cancer according to Economic Status and Region.
    Yoo S; Oh S; Cho MC; Son H; Jeong H
    Cancer Res Treat; 2023 Apr; 55(2):652-658. PubMed ID: 36510653
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Osteolytic or mixed bone metastasis is not uncommon in patients with high-risk prostate cancer.
    Kurokawa R; Kato S; Koyama H; Ishida M; Kurokawa M; Kuroda R; Ushiku T; Kume H; Abe O
    Eur J Radiol; 2022 Dec; 157():110595. PubMed ID: 36356462
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Optimization of prostate cancer patient lymph node staging via the integration of neutrophil-lymphocyte ratios, platelet-lymphocyte ratios, and
    Wang Y; Tang Y; Gao X; Gan Y; Hu S; Chen MF; Cai Y
    Prostate; 2022 Nov; 82(15):1415-1421. PubMed ID: 35860907
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Urethral and bladder neck stenosis after thulium laser enucleation of the prostate: Analysis of risk factors in a series of 1003 patients.
    Castellani D; Antonucci M; Signoretti M; Cipriani C; Vittori M; Bertolo R; Gasparri L; Dellabella M; Bove P
    Andrologia; 2022 Oct; 54(9):e14523. PubMed ID: 35789109
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy.
    Hoeh B; Flammia RS; Hohenhorst L; Sorce G; Panunzio A; Chierigo F; Nimer N; Tian Z; Saad F; Gallucci M; Briganti A; Shariat SF; Graefen M; Tilki D; Antonelli A; Terrone C; Kluth LA; Becker A; Chun FKH; Karakiewicz PI
    Surg Oncol; 2022 Jun; 42():101783. PubMed ID: 35605557
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive prostate cancer.
    Freeman MN; Jang A; Zhu J; Sanati F; Nandagopal L; Ravindranathan D; Desai A; Phone A; Nussenzveig R; Jaeger E; Caputo SA; Koshkin VS; Swami U; Basu A; Bilen MA; Agarwal N; Sartor O; Burgess EF; Barata PC
    Oncologist; 2022 Mar; 27(3):220-227. PubMed ID: 35274720
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Does the type of biopsy used for diagnosis impact subsequent treatment selection in prostate cancer patients?
    Levin BA; Lama DJ; Sussman J; Guan T; Rao M; Tobler J; Verma S; Sidana A
    Aging Male; 2022 Dec; 25(1):23-28. PubMed ID: 34983290
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system.
    Cazanave Mora JM; Del Valle García R; Pérez López L; Bequer Ariza DC; Zulueta Rodríguez O; Melchor Rodríguez A; Hernández Pérez L; López Cisneros R; Arteaga Yera AL; Silva Cabrera E; Fernández Yero JL
    J Pharm Biomed Anal; 2022 Jan; 208():114470. PubMed ID: 34798395
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cytoreductive radical prostatectomy versus systemic therapy and radiation therapy in metastatic prostate cancer: A systematic review and meta-analysis.
    Shemshaki H; Al-Mamari SA; Geelani IA; Kumar S
    Urologia; 2022 Feb; 89(1):16-30. PubMed ID: 34355602
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy of propiverine hydrochloride for urinary incontinence after robot-assisted or laparoscopic radical prostatectomy.
    Ohba K; Miyata Y; Mukae Y; Mitsunari K; Matsuo T; Sakai H
    Can J Urol; 2021 Jun; 28(3):10706-10712. PubMed ID: 34129467
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.